Abstract: The invention provides the novel use of 20(S)-protopanaxadiol in the preparation of medicaments for the treatment of depressive psychiatric disorders. The pharmacological test results indicated that the compound could remarkably increase the level of NE, 5-HT and HAV in the brains of model rats having depressive disorders, remarkably enhance tremors induced by 5-hydroxytryptophan (5-HTP) and behavioral effects induced by levodopa, and inhibit the re-uptake of 5-HT and NA.
Type:
Grant
Filed:
June 8, 2007
Date of Patent:
April 3, 2012
Assignee:
Shanghai Innovative Research Center of Traditional Chinese Medicine
Inventors:
Yongzheng Hui, Zirong Yang, Zhiqi Yang, Qiang Ge